{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:53:29Z","timestamp":1793141609919,"version":"4.5.0"},"reference-count":32,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.3892\/ol.2015.3729","type":"journal-article","created":{"date-parts":[[2015,9,18]],"date-time":"2015-09-18T06:10:50Z","timestamp":1442556650000},"page":"2931-2936","source":"Crossref","is-referenced-by-count":7,"title":["Successful treatment with lenalidomide of secondary multiple myeloma with extramedullary liver plasmacytoma in a renal transplant recipient: A case report and review of the literature"],"prefix":"10.3892","volume":"10","author":[{"given":"XIAOBAO","family":"XIE","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WEI","family":"WU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YUANDONG","family":"ZHU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DELIANG","family":"LIU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WEIMIN","family":"DONG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HAIQIAN","family":"LI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"QING","family":"LI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WEIYING","family":"GU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2015,9,18]]},"reference":[{"key":"key20180108100549_b1-ol-0-0-3729","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJM199012203232510","article-title":"Cancers complicating organ transplantation","volume":"323","author":"Penn","year":"1990","journal-title":"N Engl J Med"},{"key":"key20180108100549_b2-ol-0-0-3729","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.critrevonc.2004.11.010","article-title":"Cancer incidence after immunosuppressive treatment following kidney transplantation","volume":"56","author":"Andr\u00e9s","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"key":"key20180108100549_b3-ol-0-0-3729","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/01.tp.0000179639.98338.39","article-title":"Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression","volume":"80","author":"Caillard","year":"2005","journal-title":"Transplantation"},{"key":"key20180108100549_b4-ol-0-0-3729","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1111\/ajt.12234","article-title":"Plasma cell neoplasms in US solid organ transplant recipients","volume":"13","author":"Engels","year":"2013","journal-title":"Am J Transplant"},{"key":"key20180108100549_b5-ol-0-0-3729","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/tri.12091","article-title":"Plasmacytic post-transplant lymphoproliferative disorder: A case series of nine patients","volume":"26","author":"Karuturi","year":"2013","journal-title":"Transpl Int"},{"key":"key20180108100549_b6-ol-0-0-3729","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2169\/internalmedicine.49.3103","article-title":"Spontaneous rupture of liver plasmacytoma mimicking hepatocellular carcinoma","volume":"49","author":"Ueda","year":"2010","journal-title":"Intern Med"},{"key":"key20180108100549_b7-ol-0-0-3729","doi-asserted-by":"crossref","first-page":"172","DOI":"10.5144\/1658-3876.2012.172","article-title":"Extramedullary plasmacytoma of the liver","volume":"5","author":"El Maaroufi","year":"2012","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"key20180108100549_b8-ol-0-0-3729","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","article-title":"International staging system for multiple myeloma","volume":"23","author":"Greipp","year":"2005","journal-title":"J Clin Oncol"},{"key":"key20180108100549_b9-ol-0-0-3729","first-page":"2154","article-title":"Twenty and 25 years survival after cadaveric renal transplantation","volume":"27","author":"Mahony","year":"1995","journal-title":"Transplant Proc"},{"key":"key20180108100549_b10-ol-0-0-3729","first-page":"264","article-title":"Post-transplant lymphoproliferative disorders","author":"Harris","year":"2001","journal-title":"Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues: World Health Organization Classification of Tumours"},{"key":"key20180108100549_b11-ol-0-0-3729","doi-asserted-by":"crossref","first-page":"E665","DOI":"10.1111\/ctr.12245","article-title":"Incidence and long-term outcomes of squamous cell bladder cancer after deceased donor renal transplantation","volume":"27","author":"Davis","year":"2013","journal-title":"Clin Transplant"},{"key":"key20180108100549_b12-ol-0-0-3729","first-page":"137","article-title":"The incidence of cancer and potential role of sirolimus immunosuppression conversion on mortality among a single-center renal transplantation cohort of 1,816 patients","volume":"43","author":"Branco","year":"2011","journal-title":"Transplant Proc 2011"},{"key":"key20180108100549_b13-ol-0-0-3729","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1200\/JCO.2008.20.0857","article-title":"Lymphoma after solid organ transplantation: Risk, response to therapy, and survival at a transplantation center","volume":"27","author":"Knight","year":"2009","journal-title":"J Clin Oncol"},{"key":"key20180108100549_b14-ol-0-0-3729","first-page":"200","article-title":"Plasma cell neoplasms","author":"McKenna","year":"2008","journal-title":"WHO classification of tumours of haematopoietic and lymphoid tissues"},{"key":"key20180108100549_b15-ol-0-0-3729","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1097\/01.tp.0000203554.54242.56","article-title":"Myeloma, Hodgkin disease, and lymphoid leukemia after renal transplantation: Characteristics, risk factors and prognosis","volume":"81","author":"Caillard","year":"2006","journal-title":"Transplantation"},{"key":"key20180108100549_b16-ol-0-0-3729","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/pbc.20482","article-title":"Post-transplant multiple myeloma in a pediatric renal transplant patient","volume":"47","author":"Tcheng","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"key20180108100549_b17-ol-0-0-3729","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1182\/blood-2012-06-438549","article-title":"Early onset, EBV\u2212 PTLD in pediatric liver-small bowel transplantation recipients: A spectrum of plasma cell neoplasms with favorable prognosis","volume":"121","author":"Perry","year":"2013","journal-title":"Blood"},{"key":"key20180108100549_b18-ol-0-0-3729","doi-asserted-by":"crossref","first-page":"E137","DOI":"10.1002\/pbc.24632","article-title":"Plasmacytoma-like post-transplant lymphoproliferative disorder seen in pediatric combined liver and intestinal transplant recipients","volume":"60","author":"Plant","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"key20180108100549_b19-ol-0-0-3729","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1056\/NEJM198805053181815","article-title":"Monoclonal gammopathies in HBsAg-positive patients with renal transplants","volume":"318","author":"Renoult","year":"1988","journal-title":"N Engl J Med"},{"key":"key20180108100549_b20-ol-0-0-3729","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/0090-1229(85)90140-0","article-title":"Monoclonal gammapathies in patients undergoing immunosuppressive treatment after renal transplantation","volume":"37","author":"Radl","year":"1985","journal-title":"Clin Immunol Immunopathol"},{"key":"key20180108100549_b21-ol-0-0-3729","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/modpathol.3800080","article-title":"Post-transplant plasma cell myeloma and polymorphic lymphoproliferative disorder with monoclonal serum protein occurring in solid organ transplant recipients","volume":"17","author":"Sun","year":"2004","journal-title":"Mod Pathol"},{"key":"key20180108100549_b22-ol-0-0-3729","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1309\/AJCPX70TIHETNBRL","article-title":"Extramedullary plasmacytoma-like post-transplantation lymphoproliferative disorders: Clinical and pathologic features","volume":"132","author":"Richendollar","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"key20180108100549_b23-ol-0-0-3729","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3324\/haematol.2010.039214","article-title":"Plasmacytoma-like post-transplant lympho-proliferative disorder, a rare subtype of monomorphic B-cell post-transplant, lympho-proliferation is associated with a favorable outcome in localized as well as in advanced disease: A prospective analysis of 8 cases","volume":"96","author":"Trappe","year":"2011","journal-title":"Haematologica"},{"key":"key20180108100549_b24-ol-0-0-3729","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1080\/1042819031000067882","article-title":"Extramedullary liver plasmacytoma a rare presentation","volume":"44","author":"Petrucci","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"key20180108100549_b25-ol-0-0-3729","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1182\/blood-2014-03-544759","article-title":"How we manage autologous stem cell transplantation for patients with multiple myeloma","volume":"124","author":"Gertz","year":"2014","journal-title":"Blood"},{"key":"key20180108100549_b26-ol-0-0-3729","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1182\/blood-2011-11-390930","article-title":"Cyclophosphamide-bortezomib-dexamethasone (CyBorD) produces rapid and complete hematologic response in patients with AL amyloidosis","volume":"119","author":"Mikhael","year":"2012","journal-title":"Blood"},{"key":"key20180108100549_b27-ol-0-0-3729","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00277-011-1272-6","article-title":"Lenalidomide is active for extramedullary disease in refractory multiple myeloma","volume":"91","author":"Nakazato","year":"2012","journal-title":"Ann Hematol"},{"key":"key20180108100549_b28-ol-0-0-3729","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.clml.2012.08.005","article-title":"Lenalidomide is effective for the treatment of bortezomib-resistant extramedullary disease in patients with multiple myeloma: Report of 2 cases","volume":"13","author":"Ito","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"key20180108100549_b29-ol-0-0-3729","doi-asserted-by":"crossref","first-page":"e175","DOI":"10.1200\/JCO.2011.41.1413","article-title":"Imaging features of extramedullary, relapsed, and refractory multiple myeloma involving the liver across treatment with cyclophosphamide, lenalidomide, bortezomib, and dexamethasone","volume":"30","author":"Saboo","year":"2012","journal-title":"J Clin Oncol"},{"key":"key20180108100549_b30-ol-0-0-3729","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1600-0609.2011.01644.x","article-title":"GEM-PETHEMA\/Spanish Myeloma Group, Spain: Lenalidomide is effective for extramedullary disease in relapsed or refractory multiple myeloma","volume":"87","author":"Calvo-Villas","year":"2011","journal-title":"Eur J Haematol"},{"key":"key20180108100549_b31-ol-0-0-3729","first-page":"553","article-title":"Multiple myeloma relapse following autologous stem cell transplant presenting with diffuse pulmonary nodules","volume":"13","author":"Sumrall","year":"2013","journal-title":"Ochsner J"},{"key":"key20180108100549_b32-ol-0-0-3729","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ajh.10417","article-title":"Treatment of postrenal transplantation lymphoproliferative disease manifesting as plasmacytoma with nonmyeloablative hematopoietic stem cell transplantation from the same kidney donor","volume":"74","author":"Au","year":"2003","journal-title":"Am J Hematol"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2015.3729\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T07:30:06Z","timestamp":1515396606000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2015.3729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,18]]},"references-count":32,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,9,18]]},"published-print":{"date-parts":[[2015,11]]}},"alternative-id":["10.3892\/ol.2015.3729"],"URL":"https:\/\/doi.org\/10.3892\/ol.2015.3729","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,18]]}}}